Cargando…
Laboratory correlates of SARS-CoV-2 seropositivity in a nationwide sample of patients on dialysis in the U.S.
Patients on dialysis are at high risk for death due to COVID-19, yet a significant proportion do survive as evidenced by presence of SARS-CoV-2 antibodies in 8% of patients in the U.S. in July 2020. It is unclear whether patients with seropositivity represent the subgroup with robust health status,...
Autores principales: | Anand, Shuchi, Montez-Rath, Maria E., Han, Jialin, Garcia, Pablo, Bozeman, Julie, Kerschmann, Russell, Beyer, Paul, Parsonnet, Julie, Chertow, Glenn M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049224/ https://www.ncbi.nlm.nih.gov/pubmed/33857168 http://dx.doi.org/10.1371/journal.pone.0249466 |
Ejemplares similares
-
Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study
por: Anand, Shuchi, et al.
Publicado: (2020) -
Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic
por: Anand, Shuchi, et al.
Publicado: (2021) -
SARS-CoV-2 vaccine antibody response and breakthrough infection in dialysis
por: Anand, Shuchi, et al.
Publicado: (2021) -
Antibody Response to COVID-19 vaccination in Patients Receiving Dialysis
por: Anand, Shuchi, et al.
Publicado: (2021) -
SARS-CoV-2 infection during the Omicron surge among patients receiving dialysis: the role of circulating receptor-binding domain antibodies and vaccine doses
por: Montez-Rath, Maria E., et al.
Publicado: (2022)